InsidersTradesSigma
基于 7 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by Agah Ramtin, Directeur Médical. Insider active across 1 company, notably RenovoRx, Inc.. In total, 9 filings have been published. Breakdown: 6 buys · 0 sell. Total volume traded: €94k. Activity tracked since 16 March 2022. The latest transaction was disclosed on 5 June 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Ramtin Agah is the Chief Medical Officer at RenovoRx, Inc. He is responsible for overseeing the company's medical and research initiatives. With extensive expertise in the medical field, he plays a key role in developing new therapies and improving patient outcomes. His leadership helps position RenovoRx as a leader in the healthcare sector.